Three-year update from the optic trial: A dose-optimization study of 3 starting doses of ponatinib Meeting Abstract


Authors: Cortes, J. E.; Deininger, M. W.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; McCloskey, J.; Hochhaus, A.; Rousselot, P.; Rosti, G.; de Lavallade, H.; Rojas, C.; Turkina, A.; Maness, L.; Talpaz, M.; Mauro, M.; Lu, V.; Vorog, A.; Apperley, J. F.
Abstract Title: Three-year update from the optic trial: A dose-optimization study of 3 starting doses of ponatinib
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 1495
End Page: 1497
Language: English
ACCESSION: WOS:000893223201206
DOI: 10.1182/blood-2022-157822
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro